Correction: Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Clin Cancer Res
.
2023 Jun 13;29(12):2336.
doi: 10.1158/1078-0432.CCR-23-1170.
Authors
Funda Meric-Bernstam
,
Randy F Sweis
,
F Stephen Hodi
,
Wells A Messersmith
,
Robert H I Andtbacka
,
Matthew Ingham
,
Nancy Lewis
,
Xinhui Chen
,
Marc Pelletier
,
Xueying Chen
,
Jincheng Wu
,
Thomas W Dubensky
,
Sarah M McWhirter
,
Thomas Müller
,
Nitya Nair
,
Jason J Luke
PMID:
37309603
DOI:
10.1158/1078-0432.CCR-23-1170
No abstract available
Publication types
Editorial
Published Erratum